pharma · H. Pylori Infection · COVID-19
Jiangsu Province Centers
Jiangsu Province Centers for Disease Control and Prevention
Jiangsu Province Centers is a pharma organization headquartered in CN. Primary therapeutic focus areas include H. Pylori Infection, COVID-19. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent re
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 2
- Drugs
- 5
- Patents
- 0
H. pylori vaccine
Phase 3 · mab · H. Pylori Infection
H. pylori vaccine for H. Pylori Infection is a Phase 3 program (mab) at Jiangsu Province Centers for Disease Control and Prevention with 1 ClinicalTrials.gov record(s).
Internal code TMMUHP03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Phase
- Phase 3
- Modality
- mab
- Indication
- H. Pylori Infection
- Status
- completed
- Trials
- 1